GW501516 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-01. Numbers and descriptions here follow the published literature rather than marketing material.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 317318-70-0 | Unique identifier for the compound. |
| Chemical class | PPARδ agonist | Synthetic ligand for peroxisome proliferator-activated receptor delta. |
| Appearance | White to off-white solid | Typical form of research-grade material. |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water. |
| Typical storage | -20°C | Recommended for long-term storage of stock solutions. |
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
While research accelerators had once generated 70 percent of sales, industrial products now accounted for 80 percent. Despite the strategic pivot, HVEC struggled to achieve sustained profitability. Its subsidiaries faced intense competition from larger conglomerates. In 1981, HVEC divested from its accelerator manufacturing business. Two years later, it sold its Burlington manufacturing plant. The company refocused on smaller industrial products including specialty plastics, wire, industrial instruments, and electrical connectors. Through the 1980s, HVEC progressively sold these product lines to other manufacturing conglomerates. In 1988, private equity firm Hyde Park Partners bid to take HVEC private at roughly twice its prevailing share price. Though Levesque resisted, shareholders accepted the offer in 1989. Hyde Park dismissed existing management, sold remaining real estate, and relocated the headquarters to Charlestown, Massachusetts. The company filed for bankruptcy in 2005. Since 2019, corporate remnants have been held by Oak Point Partners.
== Empty commercial property == In April 2009, the UK government established a form of non-commercial leasing for empty commercial properties known as a "meanwhile lease", also referred to as a "meanwhile use lease" (MUL), which aims "to encourage the temporary occupation of empty town centre retail premises by non-commercial occupiers". A set of template leases was made available to enable property owners and tenants to agree a form of lease for temporary occupation. Rents are not charged, or they are low, so that charities, voluntary organisations, learning providers and local artists can occupy the property. No security of tenure is provided so the property can easily be returned to commercial use when the opportunity arises. Loan covenants and debt overhang can contribute to rental vacancy rates.
The United States has been heavily involved in the conflict since its beginnings, when in the early 1960s the U.S. government encouraged the Colombian military to attack leftist militias in rural Colombia. This was part of the U.S. fight against communism. In October 1959, the United States sent a "Special Survey Team", composed of counterinsurgency experts, to investigate Colombia's internal security situation. In February 1962, a Fort Bragg top-level U.S. Special Warfare team headed by Special Warfare Center commander General William P. Yarborough, visited Colombia for a second survey. In a secret supplement to his report to the Joint Chiefs of Staff, Yarborough encouraged the creation and deployment of a paramilitary force to commit sabotage and terrorist acts against communists:
The Center for Surveillance, Epidemiology and Laboratory Services (CSELS) was a branch of the US Centers for Disease Control and Prevention (CDC) from 2013-2022 that provided scientific service, expertise, skills, and tools in support of national efforts to promote health; prevent disease, injury and disability; and prepare for emerging health threats. It was founded in 2013 and had over 700 employees and contractors before its divisions and office of the director were reorganized. CSELS managed over 30 programs across four divisions: Division of Health Informatics and Surveillance, Division of Laboratory Systems, Division of Public Health Information Dissemination, and the Division of Scientific Education and Professional Development.
Sources: en.wikipedia.org
Commission D2: Refrigerated Transport The IIR's Commission D2 on Refrigerated Transport is extremely active. In addition to the IIR's four-yearly congress, Commission D2 participates in the IIR Conference on Sustainability and the Cold Chain, held out of synchronisation with the congress. Every year, Commission D2 CERTE test engineers meet in a European country to discuss refrigerated transport technology and testing issues. This group subsequently advises the United Nations working party on transport of perishable foodstuffs held each year in Geneva. Commission D2 is currently addressing the “Cold Chain for Pharmaceutical Products” and will add this to regular transport discussion and advisory topics. Commission D2 also helps to produce Informatory Notes to assist in areas of technical or regulatory difficulty. The IIR is recognised, for its contributions to refrigerated transport, particularly through the work of its Commission D2. The commission's research addresses food waste reduction and emissions mitigation.
In 2003–04, SOCPAC supported the AFP by training a larger number of Filipino forces. Again, 1st SFG deployed two successive force packages, consisting of one ODB and 5 ODAs, to conduct Security Assistance during 2003, and a third force package in 2004 of one ODB and 3 ODAs. In total the ODAs trained 5 AFP army and one AFP marine battalions. During the same period, 1st Battalion of 1st SFG continued training the Filipino Counterterrorist force, preparing and outfitting an additional two Light Reaction Companies (LRCs). ODAs from 1st Battalion of 1st SFG also assisted in the design of a Joint Special Operations Group (JSOG), including AFP air force rotary wing lift assets. On 30 June 2004, a U.S. Special Forces soldier from 2nd Battalion, 1st SFG, was killed in a non-hostile incident in Manila. SOCPAC also introduced Operations/Intelligence Fusion Teams (O/IFTs) to work with various organizations in AFP's Southern Command. The O/IFTs provided advice and assistance on collection priorities and force employment at division and brigade. Beginning in 2004, 1st Battalion 1st SFG provided two ODAs continuously to serve as O/IFTs, both to the newly created JSOG and to Filipino 6th Infantry Division in Mindanao. In the summer of 2005, terrorists from the ASG and JI had moved from Mindanao to Sulu where they sought refuge.
The NIH Office of the Director is the central office responsible for setting policy for the NIH, and for planning, managing, and coordinating the programs and activities of all NIH components. The NIH Director plays an active role in shaping the agency's activities and outlook. The Director is responsible for providing leadership to the Institutes and Centers by identifying needs and opportunities, especially in efforts involving multiple Institutes. Within the Director's Office is the Division of Program Coordination, Planning and Strategic Initiatives with 12 divisions including:
Thermal ionization (also known as surface ionization, or contact ionization) involves spraying vaporized, neutral atoms onto a hot surface, from which the atoms re-evaporate in ionic form. To generate positive ions, the atomic species should have a low ionization energy, and the surface should have a high work function. This technique is most suitable for alkali atoms (Li, Na, K, Rb, Cs) which have low ionization energies and are easily evaporated. To generate negative ions, the atomic species should have a high electron affinity, and the surface should have a low work function. This second approach is most suited for halogen atoms Cl, Br, I, At.
=== FRIDOC database === FRIDOC is the most comprehensive database in the world dedicated to refrigeration. It contains over 110,000 references to documents in all domains of refrigeration. A large number of the documents referenced in FRIDOC are scientific and technical. FRIDOC also contains many review articles, documents on economic data and statistics, articles dealing with regulations and standardisation, etc.
Sources: en.wikipedia.org
In 2003–04, SOCPAC supported the AFP by training a larger number of Filipino forces. Again, 1st SFG deployed two successive force packages, consisting of one ODB and 5 ODAs, to conduct Security Assistance during 2003, and a third force package in 2004 of one ODB and 3 ODAs. In total the ODAs trained 5 AFP army and one AFP marine battalions. During the same period, 1st Battalion of 1st SFG continued training the Filipino Counterterrorist force, preparing and outfitting an additional two Light Reaction Companies (LRCs). ODAs from 1st Battalion of 1st SFG also assisted in the design of a Joint Special Operations Group (JSOG), including AFP air force rotary wing lift assets. On 30 June 2004, a U.S. Special Forces soldier from 2nd Battalion, 1st SFG, was killed in a non-hostile incident in Manila. SOCPAC also introduced Operations/Intelligence Fusion Teams (O/IFTs) to work with various organizations in AFP's Southern Command. The O/IFTs provided advice and assistance on collection priorities and force employment at division and brigade. Beginning in 2004, 1st Battalion 1st SFG provided two ODAs continuously to serve as O/IFTs, both to the newly created JSOG and to Filipino 6th Infantry Division in Mindanao. In the summer of 2005, terrorists from the ASG and JI had moved from Mindanao to Sulu where they sought refuge.
=== Honey bee products === Honey bee products are used medicinally across Asia, Europe, Africa, Australia, and the Americas, despite the fact that the honey bee was not introduced to the Americas until the colonization by Spain and Portugal. They are by far the most common medical insect product, both historically and currently. Honey is the most frequently referenced medical bee material. It can be applied to skin to treat excessive scar tissue, rashes, and burns, and can be applied as a poultice to eyes to treat infection. It is also consumed for digestive problems and as a general health restorative, and can be heated and consumed to treat head colds, cough, throat infections, laryngitis, tuberculosis, and lung diseases. Additionally, apitoxin, or honey bee venom, can be applied via direct stings to relieve arthritis, rheumatism, polyneuritis, and asthma. Propolis, a resinous, waxy mixture collected by honeybees and used as a hive insulator and sealant, is often consumed by menopausal women because of its high hormone content, and it is said to have antibiotic, anesthetic, and anti-inflammatory properties. Royal jelly is used to treat anemia, gastrointestinal ulcers, arteriosclerosis, hypo- and hypertension, and inhibition of sexual libido. Finally Bee bread, or bee pollen, is eaten as a generally health restorative, and is said to help treat both internal and external infections. All of these honey bee products are regularly produced and sold, especially online and in health food stores, though none are yet approved by the FDA.
== Honours and awards == In the 2020 New Year Honours, Heffernan was appointed a Companion of the New Zealand Order of Merit, for services to health. On her appointment, Heffernan asked New Zealanders to play their part to reduce antibiotic resistance, saying, "While antibiotics are essential medicines to treat bacterial infections, we overuse and misuse them and this contributes to resistance". On her retirement in 2018, after a 43-year career, ESR awarded Heffernan their Lifetime Achievement Award.
The 52nd G7 Summit was an annual summit of the G7 held from 15 to 17 June 2026 in Évian-les-Bains, Haute-Savoie, France. Évian-les-Bains previously hosted the 29th G8 summit in 2003. The 2026 summit therefore makes Évian the first French town to host a G7 or G8 leaders' summit twice. At the summit, leaders issued joint statements on Ukraine, the Middle East, critical minerals and global economic imbalances, among other issues.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.
No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.
Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.